Talbros Automotive Components, Allied Blenders and Distillers and Avantel to see some action today

Talbros Automotive Components (TACL), along with its JV’s has received orders worth around Rs 580 crore for both domestic and exports market from the leading OEM’s. These orders are to be executed over the period of next 5 years. These orders include orders from all the company’s product lines like gaskets, heat shields, forging components, chassis and hoses.

Allied Blenders and Distillers has received board’s approval for the acquisition of 100% of the equity share capital of UTO Asia (UTO Asia), a company incorporated under the laws of Singapore. The total consideration of this acquisition is Euro 1,225,000 (excluding stamp duty and levies). The binding transaction documents have been executed, and the acquisition is concluded with immediate effect.

Avantel’s wholly owned subsidiary -- Imeds Global (iMeds) has set up a facility for Design, Development, and Manufacturing of Medical Products at Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam. The facility is spread over 2 acres of land, with a built-up area of approximately 25,000 sq. ft., and is equipped with clean rooms, assembly, and testing infrastructure for manufacturing medical products. The facility is scheduled to become operational from June 15, 2025.

Hilton Metal Forging has successfully Manufactured Railway Forged Wagon Wheelset. Railway Forged Wagon Wheelset has been duly inspected and approved by RITES. One Railway Forged Wagon Wheelset consists of 2 Forged wheels and 1 Forged Axle. Each Coach/ Wagon has 4 Wagon wheelset. FY26 Hilton Metal Forging has plans of manufacturing more than 3,000 Railway Forged Wagon Wheelset. FY27 plan to increase production to more than 12,000 Railway Forged Wagon Wheelset.

Narayana Hrudayalaya’s wholly owned overseas subsidiary -- Health City Cayman Islands (HCCI) has infused an amount of $10,00,000 in Cayman Integrated Healthcare (CIHL), a wholly-owned overseas subsidiary of HCCI and a step-down subsidiary of the company by way of subscription to its equity shares equivalent to $1 million, i.e., 1,00,000 ordinary shares in the capital of the company, each as fully paid, with the value of each ordinary shares being set at $10.00, which is comprised $0.01 of par value and $9.99 of share premium. The above-mentioned shares have been allotted by CIHL to HCCI on June 10, 2025. With this investment, the total investment of HCCI in CIHL stands at $8,050,000.

OneSource Specialty Pharma has entered into a partnership focused on the commercial manufacturing of Xbrane’s biosimilar portfolio. As part of the agreement, Xbrane will tech transfer its select product(s) to OneSource’s state-ofthe-art integrated Drug Substance and Drug Product (DS/DP) facility in Bangalore, India. The collaboration aims to strengthen Xbrane’s global supply chain, while enabling OneSource to accelerate regulatory approvals, including from the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), for its biologics drug substance facility. As part of the collaboration, OneSource has also participated in Xbrane’s latest funding round, reinforcing the long-term alignment between the two companies.

Veranda Learning Solutions has grown leaps and bounds through organic and inorganic route over the last few years. It has now initiated a major restructuring exercise under its Veranda 2.0 vision-primarily aimed at unlocking long-term value, enabling focused growth, and sharpening operational agility in the rapidly evolving education sector by carefully studying the synergies between its various businesses and unbundling / rebundling operations of its 4 key verticals namely, academic, commerce, government test prep and vocational training.